US 9040061
Topical formulation for administering a compound
granted A61KA61K31/505A61K31/635
Quick answer
US patent 9040061 (Topical formulation for administering a compound) held by Rigel Pharmaceuticals, Inc. expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/505, A61K31/635, A61K47/10, A61K9/0014